![Jeuveau vials with shadow.](https://cdn.prod.website-files.com/6679ed659d8fe8e03a8a0da9/6788460870c47a84b0035341_Combination-White-Jeuveau-vials-T%201.png)
![Jeuveau vials.](https://cdn.prod.website-files.com/6679ed659d8fe8e03a8a0da9/678848ca7a8a0f7aa559fc69_Combination-White-Jeuveau-vials-T-1-no-shadow.png)
Our flagship product Jeuveau® is a proprietary neurotoxin indicated to temporarily improve the look of moderate to severe frown lines in adults. For the fourth consecutive year, Jeuveau has been the fastest growing neurotoxin in the U.S.
A performance beauty company building an aesthetics portfolio of consumer brands in the cash-pay aesthetics market. Our company name is derived from the word Evolution. We’ve evolved the medical aesthetics business model by intentionally moving away from a reimbursement model and partnering with customers differently to provide greater value.
Our flagship product Jeuveau® is a proprietary neurotoxin indicated to temporarily improve the look of moderate to severe frown lines in adults. For the fourth consecutive year, Jeuveau has been the fastest growing neurotoxin in the U.S.
Evolysse is the next generation injectable hyaluronic acid made with Cold-X™ Technology. The Evolysse collection launches in 2025 with two injectable hyaluronic acid gels, each with unique viscoelasticity properties to soften wrinkles that form in dynamic areas of the face such as the nasolabial folds.
ONE MILLION ENROLLED
CONSUMERS
Now celebrating one million consumers in Evolus Rewards, the only co-branded patient loyalty program designed to help practices grow by rewarding every patient, every time.*
EVERY TREATMENT,
EVERY TIME*
*patients eligible once every 90 days